Treatment for lupus nephritis-Reference-Cited by-同舟云学术

Treatment for lupus nephritis

Published:2012-12-12 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Henderson Lorna¹,Masson Philip²,Craig Jonathan C²³,Flanc Robert S⁴,Roberts Matthew A⁵,Strippoli Giovanni FM²³⁶⁷⁸,Webster Angela C¹²³

Affiliation:

1. The University of Sydney at Westmead; Centre for Transplant and Renal Research, Westmead Millennium Institute; Westmead NSW Australia 2145

2. The University of Sydney; Sydney School of Public Health; Sydney Australia

3. The Children's Hospital at Westmead; Cochrane Renal Group, Centre for Kidney Research; Westmead NSW Australia 2145

4. Monash Medical Centre; Department of Nephrology; Clayton Rd Clayton VIC Australia 3168

5. Austin Health; Department of Nephrology; PO Box 5555 Heidelberg VIC Australia 3084

6. University of Bari; Department of Emergency and Organ Transplantation; Bari Italy 70100

7. Mario Negri Sud Consortium; Department of Clinical Pharmacology and Epidemiology; Santa Maria Imbaro Italy

8. Diaverum; Medical-Scientific Office; Lund Sweden

Publisher

Wiley

Subject

Pharmacology (medical)

Reference305 articles.

1. Abd-ELHady El-Sehemy M Al-Saaran AM Al-Saeed Baddour NM El-Sayed Moez P Adam AG Comparative clinical prospective therapeutic study between cyclophosphamide, cyclosporine and azathioprine in the treatment of lupus nephritis [abstract] 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon (Portugal) 2004 48

2. Abd-ELHady El-Sehemy M Al-Saaran AM Al-Saeed Baddour NM El-Sayed Moez P Gaber Adam A Cyclosporine but not cyclophosphamide is a rescue therapy in resistant lupus nephritis even in class iv proliferative GN [abstract] 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon (Portugal) 2004 48

3. Prospective comparative study between azathioprine "AZA", cyclophosphamide "CYP", cyclosporine "CsA" and mycophenolate mofetil "MMF" in the treatment of lupus nephritis: is CYP still the preferred therapy against the new -comer MMF. AZA: an old drug with still a great potential? [abstract];Adam;Journal of the American Society of Nephrology,2004

4. Comparative clinical prospective therapeutic study between cyclophosphamide, cyclosporine and azathioprine in the treatment of lupus nephritis;Sehemy;Egyptian Journal of Immunology/Egyptian Association of Immunologists,2006

5. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis;Appel;Journal of the American Society of Nephrology,2009

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relative efficacy and safety of calcineurin inhibitor, mycophenolate mofetil, and azathioprine as maintenance therapies for lupus nephritis: a network meta-analysis;Zeitschrift für Rheumatologie;2023-06-06

2. Lupus Nephritis;Evidence‐Based Nephrology;2022-11-18

3. Mechanism and Management of Checkpoint Inhibitor-Related Toxicities in Genitourinary Cancers;Cancers;2022-05-17

4. Assessment of Lupus Nephritis in a Multicenter Retrospective Egyptian Cohort: Initial Characteristics, Influence of Age and Gender, Outcome, and Potential Association with Disease Damage;SAUDI J KIDNEY DIS T;2022

5. Unusual presentation of fatal disseminated varicella zoster virus infection in a patient with lupus nephritis: a case report;BMC Infectious Diseases;2020-07-23